Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02212496 : Identification the Cause of Cerebral Infarction in Patients With Cancer
PhaseN/A
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- Subjects with acute ischemic stroke who presented within 7 days from symptom onset

- Subjects with unknown cause of stroke despite of initial evaluation including
electrocardiogram and brain imaging upon admission

- Subjects who performed brain magnetic resonance image (MRI) and MR angiography (MRA),
cardiac work-ups (12-lead electrocardiography, transthoracic and/or transesophageal
echocardiography with injection of agitated saline (or agitated saline transcranial
Doppler monitoring), and 24-hour Holter and/or telemonitoring)

- Subjects with informed consent

Exclusion Criteria:

- Subjects with single subcortical infarction

- Subjects with primary brain tumor
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02212496      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740